According to DSM, Microbia has developed a highly effective technology platform that enables it to produce high quality, natural carotenoids (including β-carotene and canthaxanthin), nutritional products and other specialty materials and chemicals from renewable resources.
DSM will incorporate Microbia’s proprietary platform and R&D capabilities in support of the ongoing development of its natural carotenoids market.
“The acquisition of Microbia represents a significant step for DSM in our strategy to accelerate our innovation activities in natural products and fermentation processes. This acquisition allows us to expand our product portfolio as well as our research and development capabilities,” commented Leendert Staal, president and CEO of DSM Nutritional Products, in a company press release.
The terms of the acquisition will not be disclosed.